611 related articles for article (PubMed ID: 21172787)
21. Current options in antifungal pharmacotherapy.
Mohr J; Johnson M; Cooper T; Lewis JS; Ostrosky-Zeichner L
Pharmacotherapy; 2008 May; 28(5):614-45. PubMed ID: 18447660
[TBL] [Abstract][Full Text] [Related]
22. Newer antifungal agents.
Larru B; Zaoutis TE
Curr Opin Pediatr; 2013 Feb; 25(1):110-5. PubMed ID: 23263025
[TBL] [Abstract][Full Text] [Related]
23. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections.
Cornely OA
Infection; 2008 Aug; 36(4):296-313. PubMed ID: 18642109
[TBL] [Abstract][Full Text] [Related]
24. Overview of treatment options for invasive fungal infections.
Pound MW; Townsend ML; Dimondi V; Wilson D; Drew RH
Med Mycol; 2011 Aug; 49(6):561-80. PubMed ID: 21366509
[TBL] [Abstract][Full Text] [Related]
25. Advances in antifungal therapy.
Sable CA; Strohmaier KM; Chodakewitz JA
Annu Rev Med; 2008; 59():361-79. PubMed ID: 17967129
[TBL] [Abstract][Full Text] [Related]
26. Antifungal serum concentration monitoring: an update.
Goodwin ML; Drew RH
J Antimicrob Chemother; 2008 Jan; 61(1):17-25. PubMed ID: 17999982
[TBL] [Abstract][Full Text] [Related]
27. Antifungal treatment in pediatric patients.
Zaoutis TE; Benjamin DK; Steinbach WJ
Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
[TBL] [Abstract][Full Text] [Related]
28. Invasive fungal infections in liver transplantation.
Liu X; Ling Z; Li L; Ruan B
Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708
[TBL] [Abstract][Full Text] [Related]
29. Clinical indications for newer antifungal agents.
Naeger-Murphy N; Pile JC
J Hosp Med; 2009 Feb; 4(2):102-11. PubMed ID: 19219926
[TBL] [Abstract][Full Text] [Related]
30. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine.
Chamilos G; Kontoyiannis DP
Curr Opin Infect Dis; 2006 Aug; 19(4):380-5. PubMed ID: 16804387
[TBL] [Abstract][Full Text] [Related]
31. Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review.
Sun HY; Singh N
Int J Antimicrob Agents; 2010 Mar; 35(3):211-8. PubMed ID: 20036518
[TBL] [Abstract][Full Text] [Related]
32. Terbinafine: a pharmacological and clinical review.
Krishnan-Natesan S
Expert Opin Pharmacother; 2009 Nov; 10(16):2723-33. PubMed ID: 19874252
[TBL] [Abstract][Full Text] [Related]
33. Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.
Almyroudis NG; Segal BH
Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1451-66. PubMed ID: 21133669
[TBL] [Abstract][Full Text] [Related]
34. Treatment options for invasive fungal infections.
Dodds Ashley ES
Pharmacotherapy; 2006 Jun; 26(6 Pt 2):55S-60S. PubMed ID: 16716123
[TBL] [Abstract][Full Text] [Related]
35. Increasing fungal infections in the intensive care unit.
De Pauw BE
Surg Infect (Larchmt); 2006; 7 Suppl 2():S93-6. PubMed ID: 16895517
[TBL] [Abstract][Full Text] [Related]
36. New facets of antifungal therapy.
Chang YL; Yu SJ; Heitman J; Wellington M; Chen YL
Virulence; 2017 Feb; 8(2):222-236. PubMed ID: 27820668
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy.
Anaissie EJ
Best Pract Res Clin Haematol; 2008 Dec; 21(4):683-90. PubMed ID: 19041608
[TBL] [Abstract][Full Text] [Related]
38. Prevention and treatment of invasive fungal diseases in neutropenic patients.
Almyroudis NG; Segal BH
Curr Opin Infect Dis; 2009 Aug; 22(4):385-93. PubMed ID: 19506476
[TBL] [Abstract][Full Text] [Related]
39. Invasive mycoses: strategies for effective management.
Kontoyiannis DP
Am J Med; 2012 Jan; 125(1 Suppl):S25-38. PubMed ID: 22196206
[TBL] [Abstract][Full Text] [Related]
40. Invasive mycoses: diagnostic challenges.
Ostrosky-Zeichner L
Am J Med; 2012 Jan; 125(1 Suppl):S14-24. PubMed ID: 22196205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
